Neutropenia at baseline could indicate poor prognosis in low/intermediate risk myelodysplastic syndrome patients.
Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy. breccia@bce.uniroma1.it
Massimo
M
Breccia
Giuseppina
G
Loglisci
Adriano
A
Salaroli
Paola
P
Finsinger
Alessandra
A
Serrao
Luigi
L
Petrucci
Giuliana
G
Alimena
D000753:Anemia, Refractory / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications*; D009503:Neutropenia / Q000175:diagnosis* / Q000209:etiology*